Forte Biosciences (FBRX) FCF Margin (2017 - 2019)
Forte Biosciences (FBRX) posted quarterly FCF Margin of 8244.44% for Q4 2019, up 12081111.0% year-over-year from N/an in Q4 2018, and down 25.98% quarter-over-quarter from 6544.44% in Q3 2019.
Powered by 
Analysis
Forte Biosciences (FBRX) FCF Margin (2017 - 2019) Analysis & Trends
Forte Biosciences (FBRX) has reported FCF Margin for 3 consecutive years, with 8244.44% the latest figure, recorded in Q4 2019.
- In Q4 2019, FCF Margin rose 12081111.0% year-over-year to 8244.44%; the TTM figure through Dec 2019 stood at 8147.22% (down 795512.0% YoY), while the FY2019 annual figure was 8147.22%, down 795512.0% from the prior year.
- FCF Margin retreated to 8244.44% in Q4 2019 per FBRX's latest filing, from 6544.44% in the prior quarter.
- Across five years, FCF Margin topped out at 178955.56% in Q2 2019 and bottomed at 196755.56% in Q1 2019.
- Historically, FCF Margin has averaged 61282.77% across 3 years, with a median of 74350.0% in 2017.
- On a YoY basis, FCF Margin climbed as much as 30778889 bps in 2019 and fell as far as 5505556 bps in 2019.
- Forte Biosciences' FCF Margin stood at 96660.0% in 2017, then slumped by 34 bps to 129055.56% in 2018, then jumped by 94 bps to 8244.44% in 2019.
- Business Quant data shows FBRX's FCF Margin at 8244.44% in Q4 2019, 6544.44% in Q3 2019, and 178955.56% in Q2 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -388.28% |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 25.68% |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 22.62% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 70.82% |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -22.35% |
| 10 | Forte Biosciences | 1.58 Bn | 1.23 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | -8,244.44% |
| Sep 30, 2019 | -4,100.00% |
| Jun 30, 2019 | 177,700.00% |
| Mar 31, 2019 | -197,944.44% |
| Dec 31, 2018 | -137,944.44% |
| Sep 30, 2018 | 1.81% |
| Jun 30, 2018 | -126,888.89% |
| Mar 31, 2018 | -143,644.44% |
| Dec 31, 2017 | -94,900.00% |
| Sep 30, 2017 | -72,200.00% |
| Jun 30, 2017 | -74,580.00% |